Covid-19 Coronavirus

Medication Safety

Medication-related incidents remain one of the most frequently reported categories of patient safety incidents, accounting for about 10% of reported incidents. National organisations such as the Royal Pharmaceutical Society (RPS), Specialist Pharmacy Service (SPS), Medicines and Healthcare products Regulatory Agency (MHRA) and other regulatory bodies provide a wide range of resources that support safe medication practice, some developed in response to past drug safety concerns and alerts.

Manx Care are undertaking work in several key medication safety areas, including safer use of opioid medications, problematic polypharmacy, and safer administration of medicines in care homes.

Medication safety reports and policies

Updates of safety audits undertaken and planned improvements can be found below.

Controlled Drug Policy

COVID-19 - Adults in Primary Care LFT Testing & Antiviral Treatment

COVID-19 - Children in Primary Care LFT Testing & Antiviral Treatment

COVID-19 - Clinical Guideline: Treatment of COVID-19 (Adults And Children)

COVID-19 - Local flowchart including NICE

Methotrexate Audit Report - 2022

Pregabalin Audit Report

Switching to edoxaban criteria - November 21

Guideline for the management of acute Hyperkalaemia in Adults

Bone Health Ward Round Standard Operating Procedure (SOP)

Back to top